Table 3.
Group Abbreviation | CK (U/L) | CK-MB (U/L) | LDH (U/L) |
---|---|---|---|
N-C | 77.43 (10.6) | 8.14 (1.21) | 124.57 (9.48) |
AMI-C | 128.71 (10.63) | 28.14 (4.22) | 235.86 (32.43) |
DM-C | 126.14 (4.81) | 12.86 (1.57) | 180.57 (15.46) |
DM-AMI-C | 178.71 (15.03) | 34.43 (4.35) | 383.43 (61.77) |
S-DM-CUS-AMI | 131.86 (12.08) | 27.14 (1.86) | 252.00 (36.07) |
CUS-DM-CUS-AMI | 118.14 (11.26) | 23.71 (3.35) | 222.86 (13.02) |
S-DM-CUN-AMI | 107.86 (6.54) | 17.86 (2.79) | 191.71 (18.13) |
CUN-DM-CUN-AMI | 81.86 (7.99) | 11.43 (2.07) | 152.00 (20.84) |
Notes: values expressed as mean (standard deviation). Abbreviations: CK, creatine kinase; CK-MB, creatine kinase-MB; LDH, lactate dehydrogenase; N, normal; C, control; AMI, acute myocardial infarction; DM, diabetes mellitus; S, saline; CUS, curcumin solution in a dose of 200 mg/kg bw; CUN200, curcumin nanoparticles solution in a dose of 200 mg/kg bw.